Stemcell research will give pregnant women safer medications
The University of Oslo newspaper Titan published an article where Ragnhild Eskeland is explaining how we will use embryonic stem cells to understand the epigenetic effect on the unborn child when the mother uses medication during pregnancy. The focus is on the drug paracetamol. This study is part of PharmaTox Strategic Research Environment.
Ragnhild Eskeland holding petridishes with embryonic stem cells stained in blue. Photo: Bjarne Røsjø/UiO.